Search This Blog

Tuesday, April 23, 2013

Novartis once-daily QVA149 shows superior efficacy in reducing exacerbations, improving lung function and quality of life in COPD patients

Novartis once-daily QVA149 shows superior efficacy in reducing exacerbations, improving lung function and quality of life in COPD patients

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.